Bausch Health Announces Third-Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall St inches lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil slides on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
- Ovintiv adds 41,000 acres in Permian and Montney deals
Bausch Health Companies (BHC) PT Lowered to $14 at Stifel
November 3, 2022 1:23 PM EDTStifel analyst Annabel Samimy lowered the price target on Bausch Health Companies (NYSE: BHC) to $14.00 (from $15.00) while maintaining a Buy rating following results.
The analyst commented, "Remaining committed to the BLCO separation, BHC reported a lower 3Q22, with revenues of $2,046mn/Cons.... More
Bausch Health Companies (BHC) PT Lowered to $35 at Cowen
November 3, 2022 11:45 AM EDTCowen analyst Ken Cacciatore lowered the price target on Bausch Health Companies (NYSE: BHC) to $35.00 (from $40.00) while maintaining a Outperform rating following results.
The analyst commented, "Q3 revs reached $2.05B, in line, driven by recovery in all major segments including Salix, Solta, and... More
Bausch Health Co. Inc. (BHC) Tops Q3 EPS by 16c; Trims FY Revenue Outlook
November 3, 2022 7:17 AM EDTBausch Health Co. Inc. (NYSE: BHC) reported Q3 EPS of $1.10, $0.16 better than the analyst estimate of $0.94. Revenue for the quarter came in at $2.05 billion versus the consensus estimate of $2.07 billion.
GUIDANCE:
Bausch Health Co. Inc. sees FY2022 revenue of $8-8.17... More
